2009 Pandemic influenza A virus subtype H1N1 in Morocco, 2009-2010: epidemiology, transmissibility, and factors associated with fatal cases
- PMID: 23169979
- PMCID: PMC3572880
- DOI: 10.1093/infdis/jis547
2009 Pandemic influenza A virus subtype H1N1 in Morocco, 2009-2010: epidemiology, transmissibility, and factors associated with fatal cases
Abstract
Background: Following the emergence of 2009 pandemic influenza A virus subtype H1N1 (A[H1N1]pdm09) in the United States and Mexico in April 2009, A(H1N1)pdm09 spread rapidly all over the world. There is a dearth of information about the epidemiology of A(H1N1)pdm09 in Africa, including Morocco. We describe the epidemiologic characteristics of the A(H1N1)pdm09 epidemic in Morocco during 2009-2010, including transmissibility and risk factors associated with fatal disease.
Methods: We implemented influenza surveillance for patients presenting with influenza-like illness (ILI) at 136 private and public clinics for patients with severe acute respiratory illness (SARI) at 16 regional public hospitals from June 2009 through February 2010. Respiratory samples and structured questionnaires were collected from all enrolled patients, and samples were tested by real-time reverse-transcription polymerase chain reaction for influenza viruses. We estimated the risk factors associated with fatal disease as well as the basic reproduction number (R(0)) and the serial interval of the pandemic virus.
Results: From June 2009 through February 2010, we obtained 3937 specimens, of which 1452 tested positive for influenza virus. Of these, 1398 (96%) were A(H1N1)pdm09. Forty percent of specimens from ILI cases (1056 of 2646) and 27% from SARI cases (342 of 1291) were positive for A(H1N1)pdm09. Sixty-four deaths occurred among laboratory-confirmed A(H1N1)pdm09 SARI cases. Among these cases, those who had hypertension (age-adjusted odd ratio [aOR], 28.2; 95% confidence interval [CI], 2.0-398.7), had neurological disorders (aOR, 7.5; 95% CI, 1.5-36.4), or were obese (aOR, 7.1; 95% CI, 1.6-31.1), as well as women of gestational age who were pregnant (aOR, 2.5; 95% CI, 1.1-5.6), were at increased risk of death. Across the country, elevated numbers of locally acquired infections were detected 4 months after the detection of the first laboratory-confirmed case and coincided with the expected influenza season (October-January) in Morocco. We obtained an R(0) estimate of 1.44 (95% CI, 1.32-1.56) and a mean serial interval (±SD) of 2.3 ± 1.4 days (95% CI, 1.6-3.0).
Conclusion: Widespread but delayed community transmission of A(H1N1)pdm09 occurred in Morocco in 2009, and A(H1N1)pdm09 became the dominant influenza virus subtype during the 2009-2010 influenza season. The transmissibility characteristics were similar to those observed in other countries.
Figures
Similar articles
-
Epidemiology of 2009 pandemic influenza A virus subtype H1N1 among Kenyans aged 2 months to 18 years, 2009-2010.J Infect Dis. 2012 Dec 15;206 Suppl 1:S68-73. doi: 10.1093/infdis/jis585. J Infect Dis. 2012. PMID: 23169975
-
Epidemiology of influenza in West Africa after the 2009 influenza A(H1N1) pandemic, 2010-2012.BMC Infect Dis. 2017 Dec 4;17(1):745. doi: 10.1186/s12879-017-2839-1. BMC Infect Dis. 2017. PMID: 29202715 Free PMC article.
-
Influenza surveillance in Zambia, 2008-2009.J Infect Dis. 2012 Dec 15;206 Suppl 1:S173-7. doi: 10.1093/infdis/jis599. J Infect Dis. 2012. PMID: 23169966
-
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.Elife. 2021 Apr 16;10:e65774. doi: 10.7554/eLife.65774. Elife. 2021. PMID: 33861198 Free PMC article.
-
The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09.BMC Infect Dis. 2018 Dec 7;18(1):637. doi: 10.1186/s12879-018-3548-0. BMC Infect Dis. 2018. PMID: 30526505 Free PMC article. Review.
Cited by
-
Sodium Toxicity in the Nutritional Epidemiology and Nutritional Immunology of COVID-19.Medicina (Kaunas). 2021 Jul 22;57(8):739. doi: 10.3390/medicina57080739. Medicina (Kaunas). 2021. PMID: 34440945 Free PMC article.
-
Influenza vaccination coverage and effectiveness in young children in Thailand, 2011-2013.Influenza Other Respir Viruses. 2015 Mar;9(2):85-93. doi: 10.1111/irv.12302. Epub 2015 Jan 5. Influenza Other Respir Viruses. 2015. PMID: 25557920 Free PMC article.
-
An Overview of the 2009 A(H1N1) Pandemic in Europe: Efficiency of the Vaccination and Healthcare Strategies.J Healthc Eng. 2016;2016:5965836. doi: 10.1155/2016/5965836. J Healthc Eng. 2016. PMID: 27195658 Free PMC article. Review.
-
Comparison of methods to Estimate Basic Reproduction Number (R 0) of influenza, Using Canada 2009 and 2017-18 A (H1N1) Data.J Res Med Sci. 2019 Jul 24;24:67. doi: 10.4103/jrms.JRMS_888_18. eCollection 2019. J Res Med Sci. 2019. PMID: 31523253 Free PMC article.
-
The epidemiology of seasonal influenza after the 2009 influenza pandemic in Africa: a systematic review.Afr Health Sci. 2020 Dec;20(4):1514-1536. doi: 10.4314/ahs.v20i4.5. Afr Health Sci. 2020. PMID: 34394213 Free PMC article.
References
-
- Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–15. - PubMed
-
- Chan M. World now at the start of 2009 influenza pandemic. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6.... Accessed 9 December 2009.
-
- Kwan-Gett TS, Baer A, Duchin JS. Spring 2009 H1N1 influenza outbreak in King County, Washington. Disaster Med Public Health Prep. 2009;3(Suppl 2):S109–16. - PubMed
-
- Louie JK, Acosta M, Samuel MC, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1) Clin Infect Dis. 2011;52:301–12. - PubMed
-
- World Health Organization. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec. 2009;84:185–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous